Katherine Brennan, MD
Cardiovascular Disease · Lafayette, LANPI 1497241020
Payments from drug & device makers
Across 35 payments — averaging $34.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kestra Medical Technology Services, Inc.$205
- Novartis$189
- Abbott$170
- Medtronic$161
- Biosense Webster, Inc.$130
- AstraZeneca$90
- plus $256 from 9 others
What the payments were for
- Food & beverage$1,201100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 5 | $205 |
| Novartis | 11 | $189 |
| Abbott | 3 | $170 |
| Medtronic | 1 | $161 |
| Biosense Webster, Inc. | 1 | $130 |
| AstraZeneca | 1 | $90 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $60 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Scpharmaceuticals Inc. | 2 | $31 |
| Pfizer | 1 | $30 |
| Amgen | 1 | $19 |
| Merck | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
| Boston Scientific | 1 | $17 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$161
- HeartMate Touch$139
- Carto 3$130
How this compares
$1,201 in reported general payments places this provider in the 30th percentile of 281 cardiovascular disease providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Lafayette
- Wade MayLafayette$300K
- Corwin ThomasLafayette$30K
- Brent RochonLafayette$21K
- Ghiath MikdadiHammond$5.7M
- Marc BernsteinSlidell$2.1M
- Anil ChhabraShreveport$1.9M
- Dale PresserCovington$1.7M
- William EavesShreveport$1.6M
- Assad MouhaffelWest Monroe$1.4M
- Wenwu ZhangShreveport$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.